PPARgamma signaling and metabolism: the good, the bad and the future, Nat. Med, vol.19, pp.557-566, 2013. ,
Mechanisms of therapy-related carcinogenesis, Nat. Rev. Cancer, vol.5, pp.943-955, 2005. ,
Neuroblastoma: a malignancy due to cell differentiation block, pp.79-84, 2012. ,
An amino-terminal tetrapeptide specifies cotranslational degradation of beta-tubulin but not alpha-tubulin mRNAs, Mol. Cell. Biol, vol.14, pp.4076-4086, 1994. ,
Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter, Mol. Cell. Biol, vol.22, pp.4522-4534, 2002. ,
Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals, Mol. Cell. Neurosci, vol.6, pp.168-183, 1995. ,
Mechanisms of neuroblastoma regression, Nat. Rev. Clin. Oncol, vol.11, pp.704-713, 2014. ,
Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment, PLoS ONE, vol.8, p.62771, 2013. ,
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells, Br. J. Cancer, vol.95, pp.879-888, 2006. ,
Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway, Mitochondrion, vol.14, pp.7-17, 2014. ,
2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways, Mol. Pharmacol, vol.68, pp.119-128, 2005. ,
N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b, PLoS ONE, vol.4, p.5799, 2009. ,
Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis, Cell Cycle, vol.16, pp.59-72, 2017. ,
Expression of class III beta-tubulin in normal and neoplastic human tissues, Histochem. Cell Biol, vol.109, pp.231-239, 1998. ,
Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales, Br. J. Pharmacol, vol.170, pp.712-729, 2013. ,
Nuclear receptors, RXR, and the Big Bang, Cell, vol.157, pp.255-266, 2014. ,
A method for semiautomatic tracing and morphological measuring of neurite outgrowth from DIC sequences, Conf. Proc. IEEE Eng. Med. Biol. Soc, pp.1196-1199, 2008. ,
The peroxisome proliferatoractivated receptors: ligands and activators, Ann. N. Y. Acad. Sci, vol.804, pp.266-275, 1996. ,
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumors, Genes Chromosomes Cancer, vol.54, pp.99-109, 2015. ,
All-trans retinoic acid downregulates ALK in neuroblastoma cell lines and induces apoptosis in neuroblastoma cell lines with activated ALK, Cancer Lett, vol.297, pp.220-225, 2010. ,
Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133, Cell, vol.59, pp.675-680, 1989. ,
Changes in lipid composition of neuroblastoma C1300 N18 cell during differentiation, Neuroscience, vol.30, pp.90361-90369, 1989. ,
Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells, Differentiation, vol.59, pp.61-69, 1995. ,
Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells, Clin. Cancer Res, vol.7, pp.98-104, 2001. ,
Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferatoractivated receptor gamma, Cancer Res, vol.61, pp.3998-4002, 2001. ,
Cell Titer-Glo TN luminescent cell viability assay: a sensitive and rapid method for determining cell viability, Cell Notes, vol.2, pp.11-13, 2001. ,
ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma, Sci. Rep, vol.3, p.3450, 2013. ,
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor, Cell, vol.68, pp.397-406, 1992. ,
Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages, J. Med. Chem, vol.43, pp.1866-1877, 2000. ,
Novel synthetic oleanane triterpenoids: a series of highly active inhibitors of nitric oxide production in mouse macrophages, Bioorg. Med. Chem. Lett, vol.9, pp.3429-3434, 1999. ,
Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers, J. Biol. Chem, vol.277, pp.31491-31498, 2002. ,
Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, Mol. Cancer Ther, vol.3, pp.39-45, 2004. ,
The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism, Mol. Pharmacol, vol.59, pp.1094-1099, 2001. ,
Tumor cell rejection through terminal cell differentiation, Science, vol.238, pp.1278-1280, 1987. ,
Morphogenetic and neuronal characterization of human neuroblastoma multicellular spheroids cultured under undifferentiated and all-trans-retinoic acid-differentiated conditions, BMB Rep, vol.46, pp.276-281, 2013. ,
Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2, Mol. Pharmacol, vol.63, pp.607-616, 2003. ,
Differentiationinducing therapy for solid tumors, Curr. Pharm. Des, vol.12, pp.379-385, 2006. ,
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature, vol.358, pp.771-774, 1992. ,
Transposition and amplification of oncogene-related sequences in human neuroblastomas, Cell, vol.35, issue.2, pp.90169-90170, 1983. ,
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha, Blood, vol.110, pp.3695-3705, 2007. ,
Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells, Cancer Res, vol.63, pp.5926-5939, 2003. ,
T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities, J. Biol. Chem, vol.277, pp.19649-19657, 2002. ,
The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N-or c-myc, Mol. Cell. Biochem, vol.250, pp.91-105, 2003. ,
Neuroblastoma: from diagnosis to treatment, J. Pediatr. Oncol, vol.3, pp.38-42, 2015. ,
Protein measurement with the Folin phenol reagent, J. Biol. Chem, vol.193, pp.265-275, 1951. ,
LMNA knock-down affects differentiation and progression of human neuroblastoma cells, PLoS ONE, vol.7, p.45513, 2012. ,
Low NDRG1 mRNA expression predicts a poor prognosis in neuroblastoma patients, Pediatr. Surg. Int, vol.29, pp.363-368, 2013. ,
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group, N Engl. J. Med, vol.341, pp.1165-1173, 1999. ,
Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling, Mol. Pharmacol, vol.65, pp.309-318, 2004. ,
Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits, Spermatogenesis, vol.1, pp.121-122, 2011. ,
Targeting of the MYCN protein with small molecule c-MYC inhibitors, PLoS ONE, vol.9, p.97285, 2014. ,
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation, PLoS ONE, vol.4, p.8154, 2009. ,
Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line, Cell Growth Differ, vol.2, pp.511-518, 1991. ,
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients, Cancer Res, vol.69, pp.7338-7346, 2009. ,
The retinoid receptors, Leukemia, vol.8, pp.1-10, 1994. ,
Differentiation of malignant to benign cells, Cancer Res, vol.31, pp.127-134, 1971. ,
PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation, Biochem. Biophys. Res. Commun, vol.424, pp.421-426, 2012. ,
Neuroblastoma-remembering the three physicians who described it a century ago, Pediatr. Radiol, vol.39, pp.155-160, 2009. ,
Recent insights into the biology of neuroblastoma, Int. J. Cancer, vol.135, pp.2249-2261, 2014. ,
Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc, vol.3, pp.1101-1108, 2008. ,
NIH Image to ImageJ: 25 years of image analysis, Nat. Methods, vol.9, pp.671-675, 2012. ,
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour, Nature, vol.305, pp.245-248, 1983. ,
Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity, Cancer Res, vol.50, pp.4411-4416, 1990. ,
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines, Oncol. Res, vol.14, pp.345-354, 2004. ,
, Essential Developmental Biology, 2012.
Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors, Cancer Chemother. Pharmacol, vol.69, pp.431-438, 2012. ,
PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL, Cancer Biol. Ther, vol.6, 1967. ,
Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells, J. Biochem, vol.151, pp.611-620, 2012. ,
Definition of a continuous human cell line derived from neuroblastoma, Cancer Res, vol.30, pp.2110-2118, 1970. ,
Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro, Toxicology, vol.213, pp.157-168, 2005. ,
myc maintains embryonic stem cell pluripotency and self-renewal, Differentiation, vol.80, pp.9-19, 2010. ,
Differentiation therapy of acute promyelocytic Leukemia with tretinoin (all-trans-retinoic Acid), N. Engl. J. Med, vol.324, pp.1385-1393, 1991. ,
Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma, PLoS ONE, vol.9, p.88795, 2014. ,
Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase, Science, vol.273, pp.959-963, 1996. ,
Autoregulated instability of beta-tubulin mRNAs by recognition of the nascent amino terminus of beta-tubulin, Nature, vol.334, pp.580-585, 1988. ,
Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR, PLoS ONE, vol.6, 2011. ,
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma, N. Engl. J. Med, vol.363, pp.1324-1334, 2010. ,
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sezary syndrome cells, J. Invest. Dermatol, vol.123, pp.380-387, 2004. ,
Advances and prospects in cancer immunotherapy, New J. Sci, p.13, 2014. ,
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.10258-10263, 2013. ,